BellRing Brands (NYSE:BRBR) and ZIVO Bioscience (OTCMKTS:ZIVO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk.
Earnings and Valuation
This table compares BellRing Brands and ZIVO Bioscience’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|BellRing Brands||$988.30 million||0.96||$23.50 million||$0.61||39.52|
|ZIVO Bioscience||N/A||N/A||-$11.51 million||N/A||N/A|
This table compares BellRing Brands and ZIVO Bioscience’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk & Volatility
BellRing Brands has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.
Institutional and Insider Ownership
98.9% of BellRing Brands shares are owned by institutional investors. Comparatively, 0.1% of ZIVO Bioscience shares are owned by institutional investors. 0.0% of BellRing Brands shares are owned by insiders. Comparatively, 24.3% of ZIVO Bioscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a summary of recent ratings and recommmendations for BellRing Brands and ZIVO Bioscience, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
BellRing Brands currently has a consensus target price of $28.75, suggesting a potential upside of 19.25%. Given BellRing Brands’ higher probable upside, research analysts plainly believe BellRing Brands is more favorable than ZIVO Bioscience.
BellRing Brands beats ZIVO Bioscience on 8 of the 10 factors compared between the two stocks.
BellRing Brands Company Profile
BellRing Brands, Inc. manufactures and sells nutrition products in the United States and internationally. It offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, and nutrition bars and supplements. The company provides its products primarily under the Premier Protein, Premier Nutrition, Dymatize, PowerBar, Bell Ring, Joint Juice, and Supreme Protein brands. It sells its products through a network of channels, including club, food, drug, mass, convenience, specialty, and eCommerce; and through a broker network for customers in the convenience, grocery, and mass channels, and through distributors for the specialty channel. The company was founded in 2019 and is headquartered in Saint Louis, Missouri. BellRing Brands, Inc. is a subsidiary of Post Holdings, Inc.
ZIVO Bioscience Company Profile
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan.
Receive News & Ratings for BellRing Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BellRing Brands and related companies with MarketBeat.com's FREE daily email newsletter.